Esterase mutation is a mechanism of resistance to antimalarial compounds
Pepstatin is a known inhibitor of malarial proteases, but its activity varies between sources. Here, Istvanet al. identify a pepstatin ester as the active component of pepstatin preparations and show that this prodrug is activated by a Plasmodiumesterase, mutation of which can confer resistance to p...
Guardado en:
Autores principales: | Eva S. Istvan, Jeremy P. Mallari, Victoria C. Corey, Neekesh V. Dharia, Garland R. Marshall, Elizabeth A. Winzeler, Daniel E. Goldberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d38f9612f4048a39eb045aecf7bcf36 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Compound antimalarial ethosomal cataplasm: preparation, evaluation, and mechanism of penetration enhancement
por: Shen S, et al.
Publicado: (2015) -
The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957
por: Celia Miguel-Blanco, et al.
Publicado: (2021) -
Structural and functional insights into esterase-mediated macrolide resistance
por: Michał Zieliński, et al.
Publicado: (2021) -
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
por: Leila S. Ross, et al.
Publicado: (2018) -
Synthesis and antimalarial activity of some triphenyltin(IV) aminobenzoate compounds against Plasmodium falciparum
por: Hadi Sutopo, et al.
Publicado: (2021)